Grifols reported EUR1.21B in Cost of Sales for its fiscal quarter ending in December of 2024.


Cost Of Sales Change Date
Alaunos Therapeutics 0 18K Sep/2024
GlaxoSmithKline GBP 2.16B 241M Jun/2025
Grifols EUR 1.21B 143.12M Dec/2024
Life Technologies 15.38M 15.38M Jun/2025